Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 2
1966 1
1968 1
1969 3
1971 2
1974 2
1975 1
1977 1
1978 2
1980 2
1982 4
1983 4
1984 1
1985 1
1988 2
1989 1
1990 1
1991 2
1995 2
1996 2
1997 1
1999 2
2000 1
2001 1
2002 1
2005 1
2008 1
2009 2
2010 4
2011 6
2012 6
2013 8
2014 7
2015 7
2016 7
2017 5
2018 5
2019 8
2020 14
2021 15
2022 24
2023 18
2024 17
2025 15
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies.
Sacks-Davis R, van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, Rauch A, Mugglin C, Klein M, van der Valk M, Smit C, Jarrin I, Berenguer J, Lacombe K, Requena MB, Wittkop L, Leleux O, Bonnet F, Salmon D, Matthews GV, Guy R, Martin NK, Spelman T, Prins M, Stoove M, Hellard M; InCHEHC Collaboration. Sacks-Davis R, et al. Among authors: doyle js. Lancet HIV. 2024 Feb;11(2):e106-e116. doi: 10.1016/S2352-3018(23)00267-9. Epub 2024 Jan 12. Lancet HIV. 2024. PMID: 38224708
Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis C.
Young J, Wang S, Sacks-Davis R, Stewart A, van Santen DK, van der Valk M, Doyle JS, Matthews G, Berenguer J, Wittkop L, Lacombe K, Rauch A, Stoové M, Hellard M, Klein MB; InCHEHC Collaboration. Young J, et al. Among authors: doyle js. J Acquir Immune Defic Syndr. 2025 Jun 1;99(2):166-174. doi: 10.1097/QAI.0000000000003646. J Acquir Immune Defic Syndr. 2025. PMID: 39972551 Free article.
Joint statement in support of hepatitis C human challenge studies.
Alter HJ, Barnes E, Biondi MJ, Cox AL, Eberts JD, Feld JJ, Liang TJ, Morrison J, Rice CM, Shoukry NH, Thomas DL, Van Gennip J, Weijer C; other signatories. Alter HJ, et al. Lancet Gastroenterol Hepatol. 2023 Nov;8(11):967-969. doi: 10.1016/S2468-1253(23)00314-X. Epub 2023 Sep 21. Lancet Gastroenterol Hepatol. 2023. PMID: 37742699 Free PMC article. No abstract available.
195 results